TH

Thalassa Holdings Ltd.

A holding company active in property rentals and marine seismic & defense R&D.

THAL | IL

Overview

Corporate Details

ISIN(s):
VGG878801114
LEI:
2138002739WFQPLBEQ42
Country:
Virgin Islands (British)
Address:
FOLIO CHAMBERS, VG1110 ROAD TOWN
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Thalassa Holdings Ltd. is a holding company engaged in international business activities. The company's operations are primarily focused on two segments: Rental Income, derived from its property interests, and Product Development. The Product Development segment concentrates on marine seismic and defense research and development, including geophysical project management, related services, and the supply of equipment. The company's strategic goal is to generate long-term shareholder value by deploying capital and expertise into investment opportunities.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-29 11:39
M&A Activity
Thalassa Holdings Ltd: Trading Update
English 9.9 KB
2025-10-29 11:39
M&A Activity
Thalassa Holdings Ltd: Trading Update
English 11.4 KB
2025-10-15 09:35
Board/Management Information
Thalassa Holdings Ltd: Thalassa Board reaches agreement with Newmark Security p…
English 9.1 KB
2025-10-15 09:35
Board/Management Information
Thalassa Holdings Ltd: Thalassa Board reaches agreement with Newmark Security p…
English 10.5 KB
2025-10-08 08:30
Regulatory News Service
Thalassa Holdings Ltd: Letter to Newmark Security plc (NWT) Shareholders
English 562.7 KB
2025-10-08 08:30
Major Shareholding Notification
Thalassa Holdings Ltd: Letter to Newmark Security plc (NWT) Shareholders
English 722.8 KB
2025-09-29 10:57
Board/Management Information
Thalassa Holdings Ltd: Surgical Innovations Group plc
English 7.9 KB
2025-09-29 08:30
Interim Report
Thalassa Holdings Ltd: 2025 Interim Results
English 408.7 KB
2025-09-29 08:30
Earnings Release
Thalassa Holdings Ltd: 2025 Interim Results
English 496.5 KB

Automate Your Workflow. Get a real-time feed of all Thalassa Holdings Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Thalassa Holdings Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Thalassa Holdings Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

CIZZLE BIOTECHNOLOGY HOLDINGS PLC Logo
Developing a CIZ1B biomarker blood test for the early detection of lung cancer.
United Kingdom
CIZ
Clear Channel Outdoor Holdings, Inc. Logo
An OOH ad platform connecting brands to consumers via digital billboards and data analytics.
United States of America
CCO
CODEXIS, INC. Logo
Engineering high-performance enzymes for pharma, diagnostics, and life science manufacturing.
United States of America
CDXS
Cogent Biosciences, Inc. Logo
Developing precision small molecule therapies for cancers, autoimmune, and rare diseases.
United States of America
COGT
COMPASS Pathways plc Logo
Developing psilocybin therapies for severe mental health challenges like TRD and PTSD.
United States of America
CMPS
COMSCORE, INC. Logo
Cross-platform audience measurement and media analytics for advertisers, publishers, and agencies.
United States of America
SCOR
COPRO-HOLDINGS. Co., Ltd. Logo
Dispatches technical personnel to Japan's construction & plant industries.
Japan
7059
Corbus Pharmaceuticals Holdings, Inc. Logo
Clinical-stage oncology company developing targeted therapies like ADCs for cancer and obesity.
United States of America
CRBP
Corvus Pharmaceuticals, Inc. Logo
Develops novel, targeted therapies for immune diseases and cancer.
United States of America
CRVS
Coya Therapeutics, Inc. Logo
Developing Treg-modulating therapies for neurodegenerative and autoimmune diseases.
United States of America
COYA

Talk to a Data Expert

Have a question? We'll get back to you promptly.